ResMed MD, Lucile Blaise, explains the medical device company’s focus on delivering data informatics and analytics to patients with sleep-related diseases and disorders in the comfort of their own homes.
Very few doctors realize the dangers of sleep apnea, often referred to as a “silent killer.” ResMed is unique in raising awareness of sleep apnea and respiratory related disorders around the world. How would you characterize the awareness level in France and what initiatives are you taking to further your cause?
More than 650,000 patients are treated in France today, whereas prevalence indicates that two million people suffer from severe Obstructive Sleep Apnea (OSA)
